

Lyfius Pharma Private Limited loan details
Charges taken from banks & financial institutesData last updated:
Lyfius Pharma Private Limited has 5 charges registered with the Registrar of Companies: 3 open charges worth Rs 1,550.00 Cr and 2 satisfied charges worth Rs 700.00 Cr. The largest open charges are held by Hdfc Bank Limited and Yes Bank Limited. Lenders on record include Hdfc Bank Limited, Yes Bank Limited, State Bank Of India. The most recent charge was created on 04 Nov 2024 in favour of State Bank Of India for Rs 450.00 Cr and is closed. A charge is a security interest a company creates over its assets in favour of a lender; an open charge is still outstanding, while a satisfied charge has been repaid and closed with the Registrar. Amounts are as filed with the MCA.
Under the Companies Act, 2013 a company must register every charge on its property or assets with the Registrar of Companies within thirty days of creating it (Form CHG-1, or CHG-9 for debentures), and report its satisfaction within thirty days of repayment (Form CHG-4). The register of charges is public, so lenders, suppliers and investors can see which assets of Lyfius Pharma Private Limited are already pledged, to whom, and for how much. This page lists each charge with its holder, amount, status and the dates of creation, modification and satisfaction, along with the share of borrowing held by each lending institution.
Charges Breakdown by Lending Institutions
- Others : 1250.00 Cr
- Hdfc Bank Limited : 150.00 Cr
- Yes Bank Limited : 150.00 Cr
₹155,000.00 lakh
₹70,000.00 lakh
4
Others
Satisfaction
19 Jan 2026
₹45,000.00 lakh
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 101020599 View Details | State Bank Of India | ₹ 45,000.00 | 04 Nov 2024 | - | 19 Jan 2026 | Satisfied |
Premium access Complete charge historyUnlock the remaining charge records and filed charge documents for this company.
Verified entity values are shown only after access is granted. | ||||||